Urol. praxi. 2021;22(2):53-58 | DOI: 10.36290/uro.2021.004
Nocturia - differential diagnosis and treatment
- Urologická klinika 1. LF UK a VFN, Praha
Nocturia has a wide range of causes beyond the urological field. The main causes are polyuria, nocturnal polyuria and disorders of the collection or evacuation function of the bladder. The individual causes must be carefully distinguished from each other with the predominance of non-invasive diagnosis, as the treatment of individual causes of nocturia is diametrically different. If it is not possible to determine exactly the cause of nocturia on the basis of these methods or nocturia does not respond to the specified treatment, it is necessary to proceed to an invasive examination. The treatment of nocturia is based on the diagnosed cause and differs diametrically for individual causes of nocturia, although individual treatment modalities can also be combined.
Keywords: nocturia, noctural polyuria, overactive bladder, lower urinary tract symptoms.
Received: January 11, 2021; Revised: January 11, 2021; Accepted: January 18, 2021; Published: June 2, 2021 Show citation
References
- Mattsson S. Urinary incontinence and nocturia in healthy schoolchildren. Acta Paediatr 1994; 83: 950-954.
Go to original source... 
Go to PubMed... - Middlekoop HA, Smilde van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Subjective sleep characteristics of 1485 males and females aged 50-93: effects of sex and age, and factors related to self evaluated quality of sleep. J Gerontol A Biol Sci Med 1996; 51: 108-115. Go to original source... Go to PubMed...
- van Dijk L, Kooij DG, Schellevis FG. Nocturia in the Dutch adult population. BJU Int 2002; 90(7): 644-648. Go to original source... Go to PubMed...
- Tikkinen KA, Tammela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol 2006; 175(2): 596-600. Go to original source... Go to PubMed...
- Coyne KS, et al. The prevalence of nocturia and its effect on health-related quality of life and sleep in community sample in the USA. BJU Int 2003; 92: 948-954. Go to original source... Go to PubMed...
- Carter PG. The role of nocturnal polyuria in nocturnal urinary symptomes in healthy elderly males. 1992, MD thesis, Bristol.
- Donovan CG, Abrams P, Peters TJ, et al. The ICS-"BPH" Study: the psychometric validity and reliability of the ICS male questionnaire. Br J Urol 1996; 77: 554-562. Go to original source... Go to PubMed...
- Hald T, Nordling J, Andersen JT, et al. A patient weighted symptom score system in the evaluation of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 1991; 138: 59-62. Go to original source...
- Jackson S, Donovan J, Brookes S, et al. The Bristol female lower urinary tract symptoms questionnaire: development and psychometric testing. Br J Urol 77: 805-812.
- Kanofsky JA, Nitti VW. Tolterodine for treatment of overactive bladder. Urol Clin North Am 2006; 33(4): 447-453. Go to original source... Go to PubMed...
- Epstein BJ, Gums JG, Molina E. Newer agents for the management of overactive bladder. Am Fam Physician 2006; 74(12): 2061-2068. Go to PubMed...
- Kelleher CJ, Cardozo L, Chapple CR, et al. Improved quality of life in patients with overactive bladder symptoms treated with solifenacin. BJU Int 2005; 95(1): 81-85. Go to original source... Go to PubMed...
- Zinner N, Susset J, Gittelman M, et al. Efficacy, tolerability and safety of darifenacin, an M(3) selective receptor antagonist: an investigation of warning time in patients with OAB. Int J Clin Pract 2006; 60(1): 119-126. Go to original source... Go to PubMed...
- Staskin DR. Trospium chloride: Distinct among other anticholinergic agents available for the treatment of overactive bladder. Urol Clin North Am 2006; 33(4): 465-473. Go to original source... Go to PubMed...
- Martan A, Mašata J, Švabik K, et al. Persistence in the treatment of overactive bladder (OAB) with Mirabegron in a multicentre clinical study. Ceska Gynekol 2015; 80(4): 244-248.
- Gerber GS, Kim JH, Contreras BA, et al. An observational urodynamic evaluation of men with lower urinary tract symptoms treated with doxazosin. Urology 1996; 47: 840-844. Go to original source... Go to PubMed...
- van Venrooij GE, van Melick HH, Boon TA. Comparison of ourcomes of transurethral resection of the prostate in urodynamically obstructed versus selected urodynamically unobstructed or equivocal men. Urology 2003; 62: 672-676. Go to original source... Go to PubMed...
- Kaplan SA, et al. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. Jama 2006; 296(19): 2319-2328. Go to original source... Go to PubMed...
- MacDiarmid SA, et al. Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc 2008; 83(9): 1002-1010. Go to original source... Go to PubMed...
- Kaplan SA, et al. Solifenacin plus tamsulosin combination treatment in men with lower urinary tract symptoms and bladder outlet obstruction: a randomized controlled trial. Eur Urol 2013; 63(1): 158-165. Go to original source... Go to PubMed...
- Kaplan SA, et al. Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review. Int J Clin Pract 2011; 65(4): 487-507. Go to original source... Go to PubMed...